Meeting
2018 Gastrointestinal Cancers Symposium
Quantitative PET-MRI for early treatment response assessment in pancreatic ductal adenocarcinoma.
Authors
Martin Valera Consunji
UCSF School of Medicine, San Francisco, CA
Martin Valera Consunji , Spencer Behr , Andrew H. Ko , Margaret A. Tempero , Pelin Cinar , Zhen J. Wang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 520)
DOI
10.1200/JCO.2018.36.4_suppl.520
Abstract #
520
Poster Bd #
P20
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Inter-reader variability of imaging biomarkers for therapeutic response in pancreatic ductal adenocarcinoma.
First Author: Jon Stanley Heiselman
Poster
2018 Gastrointestinal Cancers Symposium
Discovery and validation of a quantitative, stromal-associated imaging biomarker of pancreatic ductal adenocarcinoma (PDAC).
First Author: Mohamed Zaid
Poster
2024 ASCO Annual Meeting
Cost-effectiveness of a circulating tumor fraction molecular biomarker for treatment response monitoring.
First Author: Zachary Rivers
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Association of CA19-9 and tumor size in treatment monitoring for patients with metastatic pancreatic ductal adenocarcinoma (PDAC).
First Author: Andrew Hahn